New hope for Tough-to-Treat prostate cancer in early trial

NCT ID NCT05800665

Summary

This is an early-stage study to test the safety and side effects of a new drug, RO7656594, in men with advanced or metastatic prostate cancer that has progressed after standard treatments. The main goals are to find a safe dose and see how the body processes the drug. Researchers will also look for early signs that the drug might help control the cancer.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Asan Medical Center - PPDS

    RECRUITING

    Seoul, 05505, South Korea

  • Austin Hospital

    RECRUITING

    Heidelberg, Victoria, 3084, Australia

  • British Columbia Cancer Agency

    RECRUITING

    Vancouver, British Columbia, V5Z 4E6, Canada

  • Cambridge Clinical Research Centre

    RECRUITING

    Cambridge, CB2 0AU, United Kingdom

  • Centre Léon Bérard

    RECRUITING

    Lyon, 69008, France

  • Clinica Universidad de Navarra

    RECRUITING

    Pamplona, Navarre, 31008, Spain

  • Clinica Universidad de Navarra-Madrid

    RECRUITING

    Madrid, 28027, Spain

  • HonorHealth

    RECRUITING

    Scottsdale, Arizona, 85258, United States

  • Hospital Clinico San Carlos

    RECRUITING

    Madrid, 28040, Spain

  • Hospital Universitario Vall d'Hebron - PPDS

    RECRUITING

    Barcelona, 08035, Spain

  • Institut Paoli Calmettes

    RECRUITING

    Marseille, 13009, France

  • Leicester Royal Infirmary

    RECRUITING

    Leicester, LE1 5WW, United Kingdom

  • Macquarie University Hospital

    RECRUITING

    New South Wales, New South Wales, 2162, Australia

  • Monash Health Monash Medical Centre

    RECRUITING

    Clayton, Victoria, 3168, Australia

  • Princess Margaret Hospital

    RECRUITING

    Toronto, Ontario, M5G 2M9, Canada

  • Royal Marsden Hospital - Surrey

    RECRUITING

    Sutton, SM2 5PT, United Kingdom

  • SCRI Oncology Partners

    RECRUITING

    Nashville, Texas, 37203, United States

  • Samsung Medical Center - PPDS

    RECRUITING

    Seoul, 06351, South Korea

  • Sarah Cannon Research Institute @ Florida Cancer

    RECRUITING

    Orlando, Florida, 32827, United States

  • Seoul National University Hospital

    RECRUITING

    Seoul, 03080, South Korea

  • Severance Hospital Yonsei University Health System - PPDS

    RECRUITING

    Seoul, 03722, South Korea

  • St Vincent's Hospital Sydney

    RECRUITING

    Darlinghurst, New South Wales, 2010, Australia

  • The Christie

    RECRUITING

    Manchester, M20 4BX, United Kingdom

  • University of Illinois Hospital & Health Sciences System

    RECRUITING

    Chicago, Illinois, 60612, United States

  • Yale Cancer Center

    RECRUITING

    New Haven, Connecticut, 06510, United States

Conditions

Explore the condition pages connected to this study.